Argenx
ARGX
#422
Rank
A$84.59 B
Marketcap
A$1,345
Share price
3.63%
Change (1 day)
0.49%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$2.34 Billion

According to Argenx 's latest financial reports the company's total liabilities are A$2.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.47 B8.06%
2021-12-31A$0.43 B-54.98%
2020-12-31A$0.96 B40.81%
2019-12-31A$0.68 B824.07%
2018-12-31A$74.42 M55.29%
2017-12-31A$47.92 M-26.41%
2016-12-31A$65.11 M356.98%
2015-12-31A$14.24 M-6.44%
2014-12-31A$15.23 M115.35%
2013-12-31A$7.07 M-11.5%
2012-12-31A$7.99 M56.39%
2011-12-31A$5.1 M92.33%
2010-12-31A$2.65 M